Cutera (CUTR) Competitors $0.43 -0.02 (-5.31%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$0.42 -0.01 (-3.26%) As of 02/21/2025 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends CUTR vs. NMTC, FEMY, DXR, WOK, POCI, COCH, PYPD, XAIR, SURG, and DHAIShould you be buying Cutera stock or one of its competitors? The main competitors of Cutera include NeuroOne Medical Technologies (NMTC), Femasys (FEMY), Daxor (DXR), WORK Medical Technology Group LTD Ordinary Shares (WOK), Precision Optics (POCI), Envoy Medical (COCH), PolyPid (PYPD), Beyond Air (XAIR), SurgePays (SURG), and DIH Holding US (DHAI). These companies are all part of the "medical equipment" industry. Cutera vs. NeuroOne Medical Technologies Femasys Daxor WORK Medical Technology Group LTD Ordinary Shares Precision Optics Envoy Medical PolyPid Beyond Air SurgePays DIH Holding US Cutera (NASDAQ:CUTR) and NeuroOne Medical Technologies (NASDAQ:NMTC) are both small-cap computer and technology companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, community ranking, earnings, valuation, profitability, dividends, media sentiment and institutional ownership. Which has better earnings and valuation, CUTR or NMTC? NeuroOne Medical Technologies has lower revenue, but higher earnings than Cutera. NeuroOne Medical Technologies is trading at a lower price-to-earnings ratio than Cutera, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCutera$212.37M0.04-$162.83M-$6.58-0.07NeuroOne Medical Technologies$3.45M10.29-$12.32M-$0.26-4.42 Do analysts recommend CUTR or NMTC? Cutera presently has a consensus price target of $3.00, indicating a potential upside of 597.67%. Given Cutera's stronger consensus rating and higher possible upside, equities research analysts plainly believe Cutera is more favorable than NeuroOne Medical Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cutera 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33NeuroOne Medical Technologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has more volatility & risk, CUTR or NMTC? Cutera has a beta of 1.32, suggesting that its stock price is 32% more volatile than the S&P 500. Comparatively, NeuroOne Medical Technologies has a beta of 0.48, suggesting that its stock price is 52% less volatile than the S&P 500. Does the MarketBeat Community believe in CUTR or NMTC? Cutera received 273 more outperform votes than NeuroOne Medical Technologies when rated by MarketBeat users. However, 71.59% of users gave NeuroOne Medical Technologies an outperform vote while only 63.28% of users gave Cutera an outperform vote. CompanyUnderperformOutperformCuteraOutperform Votes33663.28% Underperform Votes19536.72% NeuroOne Medical TechnologiesOutperform Votes6371.59% Underperform Votes2528.41% Do insiders & institutionals believe in CUTR or NMTC? 90.7% of Cutera shares are owned by institutional investors. Comparatively, 16.1% of NeuroOne Medical Technologies shares are owned by institutional investors. 0.4% of Cutera shares are owned by insiders. Comparatively, 8.9% of NeuroOne Medical Technologies shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Does the media prefer CUTR or NMTC? In the previous week, Cutera had 1 more articles in the media than NeuroOne Medical Technologies. MarketBeat recorded 1 mentions for Cutera and 0 mentions for NeuroOne Medical Technologies. Cutera's average media sentiment score of 0.00 equaled NeuroOne Medical Technologies'average media sentiment score. Company Overall Sentiment Cutera Neutral NeuroOne Medical Technologies Neutral Is CUTR or NMTC more profitable? NeuroOne Medical Technologies has a net margin of -82.17% compared to Cutera's net margin of -84.86%. Cutera's return on equity of 0.00% beat NeuroOne Medical Technologies' return on equity.Company Net Margins Return on Equity Return on Assets Cutera-84.86% N/A -45.07% NeuroOne Medical Technologies -82.17%-270.70%-129.70% SummaryCutera beats NeuroOne Medical Technologies on 11 of the 17 factors compared between the two stocks. Get Cutera News Delivered to You Automatically Sign up to receive the latest news and ratings for CUTR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CUTR vs. The Competition Export to ExcelMetricCuteraElectromedical equipment IndustryComputer SectorNASDAQ ExchangeMarket Cap$8.68M$3.40B$26.20B$8.95BDividend YieldN/A1.65%2.75%3.85%P/E Ratio-0.0716.9646.3418.81Price / Sales0.0474.902,537.1376.64Price / CashN/A45.9935.5737.47Price / Book-0.053.866.864.64Net Income-$162.83M$92.00M$731.18M$245.69M7 Day Performance-10.58%4.33%-2.01%-2.63%1 Month Performance-12.24%7.66%0.09%-2.37%1 Year Performance-84.13%13.25%20.23%13.65% Cutera Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CUTRCutera1.4603 of 5 stars$0.43-5.3%$3.00+597.7%-84.1%$8.68M$212.37M-0.07460Gap DownNMTCNeuroOne Medical Technologies0.119 of 5 stars$1.20+5.3%N/A+3.6%$37.03M$3.45M-2.6120FEMYFemasys3.4265 of 5 stars$1.59+15.2%$10.00+528.9%+21.0%$36.41M$1.26M-1.9630High Trading VolumeDXRDaxor3.4311 of 5 stars$7.18+0.7%$24.75+244.7%-9.5%$34.75MN/A0.0037WOKWORK Medical Technology Group LTD Ordinary SharesN/A$2.28-2.6%N/AN/A$33.06M$9.86M0.00226Lockup ExpirationGap DownPOCIPrecision Optics0.3316 of 5 stars$4.91-1.6%N/A-26.8%$31.18M$19.10M-7.9280News CoverageGap DownCOCHEnvoy Medical2.7718 of 5 stars$1.52+4.8%$8.00+426.3%+13.8%$30.78M$320,000.000.0034Gap UpHigh Trading VolumePYPDPolyPid2.3356 of 5 stars$2.95+4.2%$11.33+284.2%-44.0%$30.06MN/A-0.3880Gap UpXAIRBeyond Air4.6625 of 5 stars$0.39+4.7%$3.67+842.6%-81.0%$29.58M$1.16M-0.2870SURGSurgePays2.8477 of 5 stars$1.46-2.0%$8.50+482.2%-80.7%$29.43M$137.14M-1.2940DHAIDIH Holding US0.4216 of 5 stars$0.65+1.1%N/A-59.4%$26.15M$64.47M0.00N/AEarnings ReportGap Down Related Companies and Tools Related Companies NeuroOne Medical Technologies Alternatives Femasys Alternatives Daxor Alternatives WORK Medical Technology Group LTD Ordinary Shares Alternatives Precision Optics Alternatives Envoy Medical Alternatives PolyPid Alternatives Beyond Air Alternatives SurgePays Alternatives DIH Holding US Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CUTR) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cutera, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cutera With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.